Elizabeth G. O'Farrell
CIK: 0001744662
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 3, 2026LNSR
LENSAR, Inc.
Award(A)Direct17.4K shares- - May 20, 2026GERN
GERON CORP
Award(A)DirectStock Option (right to buy)
220K shares- - Feb 5, 2026SGP
SpyGlass Pharma, Inc.
Award(A)DirectStock Option (right to buy)
13.7K shares- - May 23, 2025LNSR
LENSAR, Inc.
Award(A)Direct7.4K shares- - May 21, 2025GERN
GERON CORP
Award(A)DirectStock Option (right to buy)
180K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 3, 2026 | LNSR LENSAR, Inc. | Award(A) | 17,421 | - | $0 | Direct |
| May 20, 2026 | GERN GERON CORP | Award(A) Stock Option (right to buy) | 220,000 | - | - | Direct |
| Feb 5, 2026 | SGP SpyGlass Pharma, Inc. | Award(A) Stock Option (right to buy) | 13,700 | - | - | Direct |
| May 23, 2025 | LNSR LENSAR, Inc. | Award(A) | 7,374 | - | - | Direct |
| May 21, 2025 | GERN GERON CORP | Award(A) Stock Option (right to buy) | 180,000 | - | - | Direct |
1-5 of 5 transactions
About O'Farrell Elizabeth G.
O'Farrell Elizabeth G. (SEC CIK 0001744662) files insider reports with the SEC as Director of LENSAR, Inc. (LNSR), Director of GERON CORP (GERN) and Director of SpyGlass Pharma, Inc. (SGP).
Signal8 holds 6 ownership filings by O'Farrell Elizabeth G. (1 Form 3, 5 Form 4), filed between May 22, 2025 and Jun 5, 2026. Those filings report 5 transactions, from May 21, 2025 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on O'Farrell Elizabeth G.'s filings is in ORLANDO, FL.
Recent filings by O'Farrell Elizabeth G.
- Jun 3, 2026: Grant or award of LNSR shares (Form 4, code A).
- May 20, 2026: Grant or award of GERN derivative securities (Form 4, code A).
- Feb 5, 2026: Grant or award of SGP derivative securities (Form 4, code A).
- May 23, 2025: Grant or award of LNSR shares (Form 4, code A).
- May 21, 2025: Grant or award of GERN derivative securities (Form 4, code A).
Other insiders filing for LENSAR, Inc. (LNSR)
- HAMMER TODD B, Director
- ELLIS THOMAS B, Director
- Wong Kendra, Principal Accounting Officer
- Connaughton Alan B., Chief Operating Officer
- CURTIS NICHOLAS T, Chief Executive Officer
- WEISNER AIMEE S, Director